Forward Citations = 94

Loading Chart...

4 inventors (with patents filed for the assignee):

Wang Shen (4 out of 44 patents)

Min Zhong (4 out of 41 patents)

Johan D Oslob (4 out of 38 patents)

4. Kenneth Jay Barr (4 out of 44 patents)

4 patents: Sort by Forward Citations

1. 7989626 - Modulators of cellular adhesion (2011-08-02),

2. 7928122 - Modulators of cellular adhesion (2011-04-19),

3. 7790743 - Modulators of cellular adhesion (2010-09-07),

4. 7745460 - Modulators of cellular adhesion (2010-06-29),

Sarcode Corporation is a leading biotechnology company specializing in developing innovative therapies for rare genetic diseases. With a focus on precision medicine, Sarcode's research and development team is dedicated to identifying and targeting specific genetic mutations to deliver personalized treatments for patients. The company's pipeline includes several promising drug candidates with the potential to address unmet medical needs in a range of rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#25 in Brisbane, CA

#13,684 in California

#59,078 in US

Brisbane, CA, United States of America

Sarcode Corporation

Forward Citations = 94

4 inventors:

Wang Shen (4 out of 44 patents)

Min Zhong (4 out of 41 patents)

Johan D Oslob (4 out of 38 patents)

4. Kenneth Jay Barr (4 out of 44 patents)

Please report any incorrect information to support@idiyas.com